LFB Biomanufacturing
Philippe Klein has extensive experience in the biomanufacturing and biotechnology fields, having held various positions at LFB since 1994. Currently serving as the BioEngineering Unit Deputy Manager, Philippe has progressed through roles including Responsable CLD and Cellular Engineering Deputy Manager. Philippe's educational background includes a Doctor of Philosophy (PhD) from the University of Sciences in Strasbourg and an Engineer's degree from Ecole Supérieure de Biotechnologie de Strasbourg, completed between 1992 and 1997 and 1988 and 1991, respectively.
LFB Biomanufacturing
LFB Biomanufacturing is an expert CDMO in the development and manufacture of recombinant proteins via cell culture, with specific know-how in the area of monoclonal antibodies (mAbs). LFB Biomanufacturing supplies a full range of bioproduction services, from the development of cell lines to the manufacturing clinical and commercial batches of active substances from biological products up to multiple pool of 2000L Cell Culture production capacities using Disposable Bioreactors Technology and exclusively Single-Use systems. The Alès site is regulary inspected by Customers as well as Health Agencies, including French-ANSM and US-FDA. LFB Biomanufacturing is subsidiary of the LFB Group.